Ratings by Stephens (Jeff Garro)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | OptimizeRX | OPRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/27/2026 | Definitive Healthcare Corp | DH | Maintain | Equal Weight (N/A) |
|
Details | ||
| 12/12/2025 | Certara Inc. | CERT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/17/2025 | OptimizeRX | OPRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/13/2025 | Evolent Health | EVH | Upgrade | Overweight (Equal Weight) |
4.45 (3.17) |
-28.76% | Details | |
| 7/15/2025 | Simulations Plus | SLP | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2025 | Simulations Plus | SLP | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2025 | Teladoc | TDOC | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/11/2025 | TruBridge Inc | TBRG | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/5/2025 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/5/2025 | Privia Health Group Inc | PRVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/31/2025 | Veradigm Inc | MDRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/21/2025 | Evolent Health | EVH | Maintain | Equal Weight (N/A) |
|
Details | ||
| 12/20/2024 | OptimizeRX | OPRX | New Coverage | Equal Weight (N/A) |
4.78 (6.74) |
41% | Details | |
| 12/20/2024 | Definitive Healthcare Corp | DH | New Coverage | Equal Weight (N/A) |
4.34 (1.18) |
-72.81% | Details | |
| 12/20/2024 | IQVIA Holdings | IQV | New Coverage | Overweight (N/A) |
190.97 (174.49) |
-8.63% | Details | |
| 12/20/2024 | Veeva Systems | VEEV | New Coverage | Overweight (N/A) |
221.54 (195.49) |
-11.76% | Details | |
| 12/20/2024 | Doximity Inc | DOCS | New Coverage | Equal Weight (N/A) |
52.19 (25.34) |
-51.45% | Details | |
| 11/20/2024 | TruBridge Inc | TBRG | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/14/2024 | Simulations Plus | SLP | New Coverage | Overweight (N/A) |
31.83 (12.22) |
-61.61% | Details | |
| 11/14/2024 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/8/2024 | Privia Health Group Inc | PRVA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | Evolent Health | EVH | Downgrade | Equal Weight (Overweight) |
24.57 (4.45) |
-81.89% | Details | |
| 10/9/2024 | Accolade Inc. | ACCD | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2024 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/1/2024 | R1 RCM Inc | RCM | Downgrade | Equal Weight (Overweight) |
12.88 (14.31) |
11.1% | Details | |
| 7/29/2024 | Teladoc | TDOC | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/10/2023 | Computer Programs and Systems | CPSI | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/30/2023 | Privia Health Group Inc | PRVA | Maintain | Overweight (N/A) |
|
Details | ||
| 9/6/2023 | NextGen Healthcare Inc | NXGN | Downgrade | Equal Weight (Overweight) |
20.55 (23.94) |
16.5% | Details | |
| 4/12/2023 | Teladoc | TDOC | New Coverage | Equal Weight (N/A) |
25.71 (5.08) |
-80.24% | Details | |
| 4/12/2023 | Veradigm Inc | MDRX | New Coverage | Equal Weight (N/A) |
12.93 (4.26) |
-67.05% | Details | |
| 4/12/2023 | R1 RCM Inc | RCM | New Coverage | Overweight (N/A) |
14.96 (14.31) |
-4.34% | Details | |
| 4/12/2023 | Privia Health Group Inc | PRVA | New Coverage | Overweight (N/A) |
27.94 (23.27) |
-16.71% | Details | |
| 4/12/2023 | Phreesia Inc. | PHR | New Coverage | Overweight (N/A) |
30.15 (12.05) |
-60.03% | Details | |
| 4/12/2023 | NextGen Healthcare Inc | NXGN | New Coverage | Overweight (N/A) |
17.11 (23.94) |
39.92% | Details | |
| 4/12/2023 | Accolade Inc. | ACCD | New Coverage | Overweight (N/A) |
13.51 (7.02) |
-48.04% | Details | |
| 4/12/2023 | Certara Inc. | CERT | New Coverage | Overweight (N/A) |
23.08 (7.06) |
-69.41% | Details | |
| 4/12/2023 | Computer Programs and Systems | CPSI | New Coverage | Equal Weight (N/A) |
30.49 (9.19) |
-69.86% | Details |
